Immune reconstitution inflammatory syndrome (IRIS) associated with Cryptococcus neoformans infection in AIDS patients

Mycoses

Volumn 54, Issue 4, 2011, Pages

  da Cunha Colombo, Eduardo Rodrigues ^a   Mora, Delio José ^a   Silva Vergara, Mario León ^a  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

Author keywords

AIDS; Cryptococcal meningitis; Cryptococcus neoformans; HAART; IRIS

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; ANTIFUNGAL AGENT; FLUCONAZOLE; LOPINAVIR PLUS RITONAVIR; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AIDS PATIENT; ANTIMICROBIAL THERAPY; ARTICLE; BRAZIL; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID CULTURE; CERVICAL LYMPHADENOPATHY; CONTROLLED STUDY; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DISEASE ASSOCIATION; DISEASE DURATION; DRUG SCREENING; FEMALE; GRANULOMATOUS INFLAMMATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INTRACRANIAL HYPERTENSION; LUMBAR PUNCTURE; LYMPH NODE; LYMPHADENITIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM MASS; MENINX DISORDER; NECROTIZING PNEUMONIA; PATIENT COMPLIANCE; PLEOCYTOSIS; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELAPSE; TREATMENT DURATION; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-HIV AGENTS; BRAZIL; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, TEACHING; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

FILOBASIDIELLA NEOFORMANS;

EID: 79959250774     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2010.01870.x     Document Type: Article

References (29)

1. Emery S, Lane C. Immune reconstitution in HIV infection. Curr Opin Immunol 1997; 9: 7568-72.
2. Palella FJ, Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. NEJM 1998; 13: 853-60.
3. Mocroft A, Ledergerber B, Katlama C et al. Decline in the AIDS and the death rates in the EuroSida study: an observational study. Lancet 2003; 362: 22-29.
4. Cheng VC, Yuen KY, Chan WM et al. Immunorestitution disease involving the innate and adaptative response. Clin Infect Dis 2000; 30: 882-92.
5. Shelburne SA III, Hamill RJ, Rodriguez-Barradas MC et al. Immune reconstitution inflammatory syndrome, emergence of a unique syndrome during highly active antiretroviral therapy. Medicine 2002; 81: 213-27.
6. Jenny-Avital ER, Abadi M. Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy. Clin Infect Dis 2002; 35: 128-33.
7. Lederman MM, Valdez H. Immune restoration with antiretroviral therapies. Implications for clinical management. Am Med Assoc 2000; 284: 223-8.
8. French MA, Price P, Stone SF. Immune restoration disease after antiretroviral therapy. AIDS 2004; 18: 1615-27.
9. Hirsch HH, Kaufmann G, Sendi P, Battegay M. Immune reconstitution in HIV infected patients. Clin Infect Dis 2004; 38: 1159-66.
10. King MD, Perlino CA, Cinnamon J, Jernigan JA. Paradoxical recurrent meningitis following therapy of cryptococcal meningitis: an immune reconstitution syndrome after initiation of highly active antiretroviral therapy. Int J STD AIDS 2002; 13: 724-6.
11. Singh N, Perfect JR. Immune reconstitution syndrome associated with opportunistic mycoses. Lancet Infect Dis 2007; 7: 395-401.
12. Cooney EL. Clinical indicators of immune restoration following highly active antiretroviral therapy. Clin Infect Dis 2002; 34: 224-33.
13. Shelburne SA, Darcourt J, White C Jr et al. The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin Infect Dis 2005; 40: 1049-52.
14. Lawn SD, Bekker LG, Myer L et al. Cryptococcal Immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme. AIDS 2005; 19: 2050-2.
15. Lortholary O, Sitbon K, Drommer F, French Cryptococcus Study Group. Evidence of HIV and Cryptococcus neoformans interactions on the pro-and anti-inflammatory responses in blood during AIDS associated cryptococcosis. Clin Microbiol Infect 2005; 11: 296-300.
16. Barbaro DJ, Orcutt VL, Coldiron BM. Mycobacterium avium-Mycobacterium intracellulare infection limited to the skin and lymph nodes in patients with AIDS. Rev Infect Dis 1989; 11: 625-8.
17. Johnson SC, Benson CA, Johnson DW, Weinberg A. Recurrences of cytomegalovirus retinitis in a human immunodeficiency virus-infected patient, despite potent antiretroviral therapy and apparent immune reconstitution. Clin Infect Dis 2001; 32: 815-9.
18. Narita M, Ashkin D, Hollender ES, Pitchenik AE. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Repir Crit Care Med 1998; 158: 157-61.
19. Jarvis JN, Harrison TS. HIV-associated cryptococcal meningitis. AIDS 2007; 21: 2119-29.
20. Kambugu A, Meya DB, Rhein J et al. Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. Clin Infect Dis 2008; 46: 1694-701.
21. Ratman I, Chiu C, Kandala NB, Easterbrook PJ. Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin Infect Dis 2006; 42: 418-27.
22. Huruy K, Mulu A, Mengistu G et al. Immune reconstitution inflammatory syndrome among HIV/AIDS patients during Highly Active Antiretroviral Therapy in Addis Ababa, Ethiopia. Jpn J Infect Dis. 2008; 61: 205-9.
23. Lawn SD, Wilkinson RJ. Immune reconstitution disease associated with parasitic infections following antiretroviral treatment. Parasite Immunol 2006; 28: 625-33.
24. Shelburne SA, Visnegarwala F, Darcourt J et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretoviral therapy. AIDS 2005; 19: 399-406.
25. Lim A, Tan D, Price P et al. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy. AIDS 2007; 21: 1525-34.
26. Cinti SK, Armstrong WS, Kauffman CA. Recurrence of increased intracranial pressure with antiretroviral therapy in an AIDS patient with cryptococcal meningitis. Mycoses 2001; 44: 497-501.
27. Trevenzoli M, Cattelan AM, Rea F et al. Mediastinitis due to cryptococcal infection: a new entityin the HAART era. J Infect 2002; 45: 173-9.
28. Robertson J, Meier M, Wall J, Ying J, Fichtenbaum CJ. Immune reconstitution syndrome in HIV: Validing a case definition and identifying clinical predictors in persons initiating antiretroviral therapy. Clin Infect Dis 2006; 42: 1639-46.
29. Tan DBA, Yong YK, Tan HY et al. Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis. British HIV Assoc HIV Med 2008; 9: 307-16.